News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
375,730 Results
Type
Article (15646)
Company Profile (115)
Press Release (359969)
Section
Business (113796)
Career Advice (496)
Deals (18773)
Drug Delivery (29)
Drug Development (36897)
Employer Resources (52)
FDA (9614)
Job Trends (8171)
News (180255)
Policy (13104)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1373)
Accelerated approval (2)
Allergies (42)
Alliances (35018)
ALS (31)
Alzheimer's disease (529)
Antibody-drug conjugate (ADC) (83)
Approvals (9647)
Artificial intelligence (232)
Autoimmune disease (3)
Automation (11)
Bankruptcy (131)
Best Places to Work (7039)
BIOSECURE Act (6)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (35)
Brain cancer (19)
Breast cancer (146)
Cancer (1253)
Cardiovascular disease (73)
Career advice (445)
Career pathing (9)
CAR-T (112)
Cell therapy (289)
Cervical cancer (16)
Clinical research (29621)
Collaboration (573)
Compensation (105)
Complete response letters (5)
COVID-19 (1209)
CRISPR (35)
C-suite (133)
Cystic fibrosis (57)
Data (1115)
Decentralized trials (1)
Denatured (18)
Depression (17)
Diabetes (97)
Diagnostics (4932)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (79)
Drug pricing (16)
Drug shortages (4)
Duchenne muscular dystrophy (28)
Earnings (39381)
Editorial (3)
Employer branding (8)
Employer resources (45)
Events (53005)
Executive appointments (375)
FDA (10256)
Featured Employer (25)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (454)
Gene editing (81)
Generative AI (23)
Gene therapy (172)
GLP-1 (238)
Government (1375)
Grass and pollen (2)
Guidances (24)
Healthcare (10199)
Huntington's disease (8)
IgA nephropathy (11)
Immunology and inflammation (32)
Indications (14)
Infectious disease (1283)
Inflammatory bowel disease (62)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (57)
Interviews (52)
IPO (8107)
IRA (9)
Job creations (1461)
Job search strategy (399)
Kidney cancer (9)
Labor market (9)
Layoffs (123)
Leadership (4)
Legal (2539)
Liver cancer (47)
Lung cancer (193)
Lymphoma (85)
Machine learning (2)
Management (17)
Manufacturing (169)
MASH (18)
Medical device (11483)
Medtech (11488)
Mergers & acquisitions (10998)
Metabolic disorders (215)
Multiple sclerosis (30)
NASH (4)
Neurodegenerative disease (29)
Neuropsychiatric disorders (3)
Neuroscience (723)
NextGen: Class of 2025 (3598)
Non-profit (1580)
Northern California (1156)
Now hiring (8)
Obesity (90)
Opinion (79)
Ovarian cancer (51)
Pain (47)
Pancreatic cancer (53)
Parkinson's disease (65)
Partnered (11)
Patents (130)
Patient recruitment (56)
Peanut (26)
People (32812)
Pharmaceutical (17)
Pharmacy benefit managers (2)
Phase I (10234)
Phase II (13275)
Phase III (9346)
Pipeline (558)
Podcasts (37)
Policy (28)
Postmarket research (704)
Preclinical (4205)
Press Release (66)
Prostate cancer (46)
Psychedelics (5)
Radiopharmaceuticals (167)
Rare diseases (159)
Real estate (3383)
Recruiting (20)
Regulatory (10049)
Reports (19)
Research institute (1320)
Resumes & cover letters (70)
Rett syndrome (3)
RNA editing (3)
RSV (22)
Schizophrenia (14)
Series A (83)
Series B (48)
Service/supplier (7)
Sickle cell disease (21)
Southern California (1177)
Special edition (1)
Spinal muscular atrophy (75)
Sponsored (14)
Startups (2509)
State (2)
Stomach cancer (5)
Supply chain (24)
The Weekly (18)
United States (11536)
Vaccines (324)
Venture capitalists (19)
Webinars (7)
Weight loss (39)
Women's health (17)
Worklife (2)
Date
Today (52)
Last 7 days (362)
Last 30 days (1432)
Last 365 days (18810)
2025 (4530)
2024 (19912)
2023 (23247)
2022 (31930)
2021 (33709)
2020 (31576)
2019 (26677)
2018 (20059)
2017 (19512)
2016 (18263)
2015 (21174)
2014 (15523)
2013 (12943)
2012 (14032)
2011 (14323)
2010 (13029)
Location
Africa (330)
Alabama (37)
Alaska (6)
Arizona (119)
Arkansas (10)
Asia (24815)
Australia (4284)
California (2902)
Canada (1019)
China (265)
Colorado (162)
Connecticut (135)
Delaware (61)
Europe (50798)
Florida (453)
Georgia (132)
Idaho (33)
Illinois (279)
India (11)
Indiana (167)
Iowa (4)
Japan (105)
Kansas (80)
Kentucky (9)
Louisiana (5)
Maine (20)
Maryland (437)
Massachusetts (2039)
Michigan (180)
Minnesota (248)
Mississippi (2)
Missouri (58)
Montana (24)
Nebraska (15)
Nevada (20)
New Hampshire (66)
New Jersey (955)
New Mexico (16)
New York (875)
North Carolina (520)
North Dakota (7)
Northern California (1156)
Ohio (104)
Oklahoma (11)
Oregon (19)
Pennsylvania (577)
Puerto Rico (7)
Rhode Island (20)
South America (522)
South Carolina (16)
South Dakota (1)
Southern California (1177)
Tennessee (56)
Texas (470)
Utah (103)
Virginia (59)
Washington D.C. (12)
Washington State (317)
West Virginia (3)
Wisconsin (35)
375,730 Results for "median technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Median Technologies Reports 2024 Key Financial Indicators and 2025 Outlook
January 31, 2025
·
12 min read
Press Releases
Median Technologies: Financial Communications Schedule for the First Half of 2025
January 14, 2025
·
1 min read
Press Releases
eyonis™ LCS, Median Technologies’ AI-Powered Software as a Medical Device for Lung Cancer Screening, Confirmed Efficacy and Safety in RELIVE Pivotal Study
March 31, 2025
·
8 min read
Press Releases
Median Technologies: eyonis™ Lung Cancer Screening (LCS) Meets Primary Endpoint in RELIVE Clinical Trial, the Final Pivotal Study Required for Regulatory Submissions
February 3, 2025
·
8 min read
Business
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”) today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited) for the first quarter of 2024, as of March 31, 2024.
April 25, 2024
·
12 min read
Press Releases
Median Technologies securing up to €47.5 million to support AI lung cancer diagnostic eyonis™ regulatory filings and commercialization in U.S. and EU
January 24, 2025
·
18 min read
Median Technologies to Participate in the 2024 ASCO Annual Meeting, May 31 - June 4, 2024, McCormick Place, Chicago, IL, USA
Median Technologies announced that the Company will be participating in the 2024 American Society of Clinical Oncology Annual Meeting taking place from May 31 to June 4, McCormick Place, Chicago, IL, USA.
May 29, 2024
·
2 min read
Business
Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook
Median Technologies announces its 2023 revenue, outlining both its strategic outlook and key milestones for 2024.
January 29, 2024
·
10 min read
Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
Regulatory News: Median Technologies announced that the Company has been selected as preferred vendor by a Top 3 pharmaceutical company, adding another one of the largest global pharmaceutical companies to its client portfolio.
May 21, 2024
·
3 min read
Press Releases
Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening
October 30, 2024
·
6 min read
1 of 37,573
Next
